ahlam1399
07-27-2015, 11:38 AM
AstraZeneca sells rare cancer drug to Sa**fi for up $300 mln
LONDON, July 27 (Reuters) - AstraZeneca, under pressure from falling sales of older *****, is selling a medicine for a rare type of cancer to Sa**fi as it continues a drive to raise cash by divesting... http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qDjWWxQXNaE:2n8JJ_6zGeY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qDjWWxQXNaE:2n8JJ_6zGeY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qDjWWxQXNaE:2n8JJ_6zGeY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qDjWWxQXNaE:2n8JJ_6zGeY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qDjWWxQXNaE:2n8JJ_6zGeY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/qDjWWxQXNaE
LONDON, July 27 (Reuters) - AstraZeneca, under pressure from falling sales of older *****, is selling a medicine for a rare type of cancer to Sa**fi as it continues a drive to raise cash by divesting... http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qDjWWxQXNaE:2n8JJ_6zGeY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qDjWWxQXNaE:2n8JJ_6zGeY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qDjWWxQXNaE:2n8JJ_6zGeY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=qDjWWxQXNaE:2n8JJ_6zGeY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=qDjWWxQXNaE:2n8JJ_6zGeY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/qDjWWxQXNaE